{"url_path":"/sec/aemd/8-k/2026-06-10/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/882291/0001683168-26-004707-index.html","accession_number":"0001683168-26-004707","cik":"0000882291","ticker":"AEMD","issuer_name":"AETHLON MEDICAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/882291/0001683168-26-004707-index.html","primary_entity_key":"0000882291","primary_entity_name":"AETHLON MEDICAL INC"},"word_count":183,"has_tables":true,"body_markdown":"** **\n\n**Item\n7.01. Regulation FD Disclosure.**\n\n \n\nOn June 10, 2026, Aethlon\nMedical, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended March 31, 2026.\nA copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.\n\n \n\nThe information set forth under Item 7.01 of this Current Report, including\nExhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities\nExchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information\nin Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities\nAct of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly\nset forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information\nin this Current Report that is required to be disclosed solely by Regulation FD"}